These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28442344)

  • 1. miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway.
    Kim J; Jiang J; Badawi M; Schmittgen TD
    Biochem Biophys Res Commun; 2017 Jun; 487(3):709-715. PubMed ID: 28442344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway.
    Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N
    Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOTAIR/miR-326/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K/AKT/mTOR pathway.
    Pan S; Liu Y; Liu Q; Xiao Y; Liu B; Ren X; Qi X; Zhou H; Zeng C; Jia L
    Biochim Biophys Acta Mol Cell Res; 2019 May; 1866(5):750-760. PubMed ID: 30742932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.
    Sun L; Wang L; Chen T; Yao B; Wang Y; Li Q; Yang W; Liu Z
    J Cell Mol Med; 2019 Dec; 23(12):8292-8304. PubMed ID: 31576658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS
    Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway.
    Zhang Z; Zhu J; Huang Y; Li W; Cheng H
    Diagn Pathol; 2018 Nov; 13(1):85. PubMed ID: 30390677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.
    Park NR; Cha JH; Jang JW; Bae SH; Jang B; Kim JH; Hur W; Choi JY; Yoon SK
    Biochem Biophys Res Commun; 2016 Sep; 477(4):568-574. PubMed ID: 27320862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma.
    Rahmani F; Ziaeemehr A; Shahidsales S; Gharib M; Khazaei M; Ferns GA; Ryzhikov M; Avan A; Hassanian SM
    J Cell Physiol; 2020 May; 235(5):4146-4152. PubMed ID: 31663122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
    Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
    Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133a alleviates airway remodeling in asthtama through PI3K/AKT/mTOR signaling pathway by targeting IGF1R.
    Shao Y; Chong L; Lin P; Li H; Zhu L; Wu Q; Li C
    J Cell Physiol; 2019 Apr; 234(4):4068-4080. PubMed ID: 30146725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OIP5, a target of miR-15b-5p, regulates hepatocellular carcinoma growth and metastasis through the AKT/mTORC1 and β-catenin signaling pathways.
    Li H; Zhang J; Lee MJ; Yu GR; Han X; Kim DG
    Oncotarget; 2017 Mar; 8(11):18129-18144. PubMed ID: 28184024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
    Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
    Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activation.
    Dong Z; Qi R; Guo X; Zhao X; Li Y; Zeng Z; Bai W; Chang X; Hao L; Chen Y; Lou M; Li Z; Lu Y
    Biochem Biophys Res Commun; 2017 Jan; 483(1):630-637. PubMed ID: 27998765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway.
    Li TT; Zhu D; Mou T; Guo Z; Pu JL; Chen QS; Wei XF; Wu ZJ
    Mol Immunol; 2017 Jul; 87():132-140. PubMed ID: 28433890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma.
    Zhu XC; Dong QZ; Zhang XF; Deng B; Jia HL; Ye QH; Qin LX; Wu XZ
    Int J Mol Med; 2012 Dec; 30(6):1321-6. PubMed ID: 23023935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA HAGLROS promotes cell proliferation, inhibits apoptosis and enhances autophagy via regulating miR-5095/ATG12 axis in hepatocellular carcinoma cells.
    Wei H; Hu J; Pu J; Tang Q; Li W; Ma R; Xu Z; Tan C; Yao T; Wu X; Long X; Wang J
    Int Immunopharmacol; 2019 Aug; 73():72-80. PubMed ID: 31082725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulfide promotes autophagy of hepatocellular carcinoma cells through the PI3K/Akt/mTOR signaling pathway.
    Wang SS; Chen YH; Chen N; Wang LJ; Chen DX; Weng HL; Dooley S; Ding HG
    Cell Death Dis; 2017 Mar; 8(3):e2688. PubMed ID: 28333142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ponatinib inhibits the proliferation of SNU-449 human hepatocellular cancer cells and blocks MAPK and PDK1/AKT/mTOR signaling pathways].
    Liu C; Pei J; Mu X; Yu B; Gong T; Liang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 May; 38(5):425-431. PubMed ID: 35603651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baicalein, a Natural Anti-Cancer Compound, Alters MicroRNA Expression Profiles in Bel-7402 Human Hepatocellular Carcinoma Cells.
    Bie B; Sun J; Li J; Guo Y; Jiang W; Huang C; Yang J; Li Z
    Cell Physiol Biochem; 2017; 41(4):1519-1531. PubMed ID: 28351032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.